Effects of a single intravenous dose of scopolamine on the quantitative EEG in Alzheimer's disease patients and age-matched controls

Electroencephalography and Clinical Neurophysiology

Volumn 91, Issue 6, 1994, Pages 407-412

  Neufeld, M Y ^a   Rabey, M J ^a   Parmet, Y ^b   Sifris, P ^a   Treves, T A ^a   Korczyn, A D ^a,b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Acetylcholine; Alzheimer's disease; Dementia; Quantitative EEG; Scopolamine

Indexed keywords

PLACEBO; SCOPOLAMINE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELTA RHYTHM; DEMENTIA; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; SCOPOLAMINE;

EID: 0028568084     PISSN: 00134694     EISSN: None     Source Type: Journal    
DOI: 10.1016/0013-4694(94)90162-7     Document Type: Article

References (34)

1. Effect of cholinergic and anticholinergic drugs on short term memory in Alzheimer's dementia; a neurophysiological and computerized electroencephalographic study
2. Changes in the human visual evoked potential caused by the anticholinergic agent hyoscine hydrobromide: comparison with results in Alzheimer's disease
3. Evidence for a direct cholinergic involvement in the scopolamine induced amnesia in monkeys: evidence in concurrent administration of physostigmine and methylphenidine with scopolamine
4. The cholinergic hypothesis of geriatric memory dysfunction
5. Computerized EEG spectral analysis in elderly normal, demented and depressed subjects
6. Topographic EEG changes with normal aging and SDAT
7. Nucleus basalis and thalamic control of the neocortical activity in the freely moving rat
8. Physostigmine and arecholine effects of intravenous infusion in Alzheimer's present dementia
9. Frequency analysis of the resting awake EEG in mild senile dementia of the Alzheimer type
10. Acetylcholine, aging and Alzheimer's disease: implications of treatment
11. Alzheimer's disease: a disorder of cortical cholinergic innervation
12. Selective loss of cholinergic neurons in Alzheimer's disease
13. Activity of identified cortically projecting and other basal forebrain neurons during large slow waves and cortical activation in anesthetized rats
14. Human memory and cholinergic system
15. Clinical effects of choline in Alzheimer's disease
16. The organization and some projections of the cholinergic neurons of the mammalian forebrain
17. “Mini mental state”, a practical method for grading the cognitive state of patients for the clinician
18. Cerebral blood flow in dementia
19. Development of a rating scale for primary depressive illness
20. Acetylcholinesterase rich projections from the basal forebrain of the rhesus monkey to neocortex
21. Computerized EEG frequency analysis and topographic brain mapping in Alzheimer's disease
22. Oral physostigmine treatment of patients with Alzheimer's disease.
23. Quantitative analysis of occipital EEG in different stages of Alzheimer's disease
24. Lesions of nucleus basalis alter ChAT activity and EEG in rat frontal neocortex
25. Effects of scopolamine (0.25−0.75 mg i.m.) on the quantitative EEG and the neuropsychological status of healty volunteers
26. EEG findings in senile dementia and normal aging
27. Longitudinal EEG spectral analysis in early stage of Alzheimer's disease
28. Serial EEG in Alzheimer's disease: 3 year follow-up and clinical outcome
29. Changes in absolute power values of the EEG spectra in the follow-up of Alzheimer's disease
30. Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age matched controls
31. Evaluation of short mental test for the diagnosis of dementia
32. A standardized memory scale for clinical use
33. Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis